Clinical Trials Directory

Trials / Completed

CompletedNCT04027283

Acute Effects of the Two Alternative Sweeteners D-allulose and Erythritol on Metabolism

Acute Effects of the Two Alternative Sweeteners D-allulose and Erythritol on Gastrointestinal Hormone Secretion and Glycemic Control

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The aim of this project is to investigate the effect of intragastric (ig) D-allulose on metabolic parameters in general and to investigate the effect of sweet taste receptor blockade on GI hormone responses, glycemic control, gastric emptying (GE) rates and appetite-related sensations to ig administration of erythritol and D-allulose.

Detailed description

Erythritol (natural non-caloric sweetener) could be an ideal candidate substitute for sugar as it may reduce caloric intake without compensatory overeating or earlier return of hunger. Moreover, it may serve as a physiological tool to disentangle the effects of gastrointestinal (GI) sweet taste receptor stimulation, (an)orexigenic hormone secretion, and glucose metabolism/caloric content on food intake regulation in vivo in humans. However, its effects on appetite, satiation, and satiety have not been studied systematically. Moreover, the mechanisms underlying erythritol-induced anorexigenic GI hormone release have not been investigated so far. D-allulose is a sugar substitute with almost zero calories and is naturally occurring in small quantities. Apart from its use as sugar replacement, D-allulose seems to favorably affect glycemic control and metabolism as could be shown in animal trials and in a few human trials. However, to date the effects of D-allulose on GI hormone secretion, appetite-related sensations and glycemic control, are not or insufficiently studied in humans. The aim of this project is therefore to investigate the effect of intragastric (ig) D-allulose on metabolic parameters in general and to investigate the effect of sweet taste receptor blockade on GI hormone responses, glycemic control, gastric emptying (GE) rates and appetite-related sensations to ig administration of erythritol and D-allulose.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTErythritol50g erythritol dissolved in 300mL tap water
DIETARY_SUPPLEMENTErythritol + lactisole50g erythritol + lactisole (450ppm) dissolved in 300mL tap water
DIETARY_SUPPLEMENTD-allulose25g D-allulose dissolved in 300mL tap water
DIETARY_SUPPLEMENTD-allulose + lactisole25g D-allulose + lactisole (450ppm) dissolved in 300mL tap water
DIETARY_SUPPLEMENTTap water300mL tap water
DIETARY_SUPPLEMENTTap water + lactisole300mL tap water + lactisole (450ppm)

Timeline

Start date
2019-09-01
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2019-07-19
Last updated
2020-09-29

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04027283. Inclusion in this directory is not an endorsement.